segunda-feira, 13 de junho de 2016

Ciência sem valor

"A former researcher at Amgen Inc has found that many basic studies on cancer -- a high proportion of them from university labs -- are unreliable, with grim consequences for producing new medicines in the future.
"During a decade as head of global cancer research at Amgen, C. Glenn Begley identified 53 "landmark" publications -- papers in top journals, from reputable labs -- for his team to reproduce. Begley sought to double-check the findings before trying to build on them for drug development.
"Result: 47 of the 53 could not be replicated. He described his findings in a commentary piece published on Wednesday in the journal Nature."
A former researcher at Amgen Inc has found that many basic studies on cancer -- a high proportion of them from university labs -- are unreliable, with grim consequences for producing new medicines in the future.
reuters.com|Por Sharon Begley

As pessoas também compartilharam

Nenhum comentário:

Postar um comentário